Ligand Pharmaceuticals
LGND
LGND
207 hedge funds and large institutions have $1.67B invested in Ligand Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 70 increasing their positions, 80 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
207
Holders Change
-13
Holders Change %
-5.91%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
22
Increased
70
Reduced
80
Closed
35
Calls
$7.21M
Puts
$3.44M
Net Calls
+$3.77M
Net Calls Change
-$14.7M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$23M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$8.29M |
| 3 |
Morgan Stanley
New York
|
+$7.27M |
| 4 |
CC
Chicago Capital
Chicago,
Illinois
|
+$6.22M |
| 5 |
DMKJ
David M. Knott Jr
|
+$4.5M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EWA
226
EverSource Wealth Advisors
Birmingham,
Alabama
| – | -$10K | -99 | Closed |
|
|
SCA
227
Snowden Capital Advisors
New York
| – | -$8K | -83 | Closed |
|
|
TWA
228
TCI Wealth Advisors
Tucson,
Arizona
| – | -$7K | -69 | Closed |
|
229
AssetMark Inc
Concord,
California
| – | -$3K | -32 | Closed |
|
|
BEI
230
Benjamin Edwards Inc
Clayton,
Missouri
| – | -$3K | -30 | Closed |
|
|
ST
231
Sageworth Trust
Lancaster,
Pennsylvania
| – | -$2K | -26 | Closed |
|
|
UB
232
UMB Bank
Kansas City,
Missouri
| – | -$1K | -10 | Closed |
|